Jennifer Jarrett

Director at Arcus Biosciences

Ms Jarrett has served as a member of our board since January 2019. Ms Jarrett currently serves as Vice President, Corporate Development and Capital Markets at Uber and is responsible for all of their M&A and capital markets activities. Most recently, she served as CFO and COO at Arcus Biosciences, where she was responsible for finance, accounting, investor relations, strategy, human resources and business development. Ms Jarrett played an important role in leading Arcus’s initial public offering. Prior to joining Arcus, she served as CFO at Medivation until its acquisition by Pfizer in 2016.

Prior to Medivation, Ms Jarrett spent 20 years in investment banking, most of that time covering biotechnology companies. Ms Jarrett served as a Managing Director at Citigroup where she headed up their west coast life sciences investment banking group. Ms Jarrett also worked in the investment banking divisions of Credit Suisse, Donaldson, Lufkin & Jenrette, Merrill Lynch, and Kidder Peabody. Ms Jarrett currently serves on the Board of Directors of Arena Pharmaceuticals, Audentes Therapeutics and Syndax Pharmaceuticals.

Timeline

  • Director

    Current role